BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23270421)

  • 1. The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients.
    Gudmundsdottir ET; Barkardottir RB; Arason A; Gunnarsson H; Amundadottir LT; Agnarsson BA; Johannsson OT; Reynisdottir I
    BMC Cancer; 2012 Dec; 12():621. PubMed ID: 23270421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women.
    Ruiz-Narváez EA; Rosenberg L; Cozier YC; Cupples LA; Adams-Campbell LL; Palmer JR
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1320-7. PubMed ID: 20406955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reserch of the gene polymorphism TOX3 / LOC643714 and the risk of breast cancer development in persons exposed to ionizing radiation after Chornobyl disaster.
    Polinyk SI; Rybchenko LA; Klimyk BT
    Probl Radiac Med Radiobiol; 2017 Dec; 22():450-462. PubMed ID: 29286526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population.
    Tajbakhsh A; Javan FA; Rivandi M; Moezzi A; Abedini S; Asghari M; Farjami Z; Soltanian H; Shandiz FH; Kooshyar MM; Pasdar A
    Mol Biol Rep; 2019 Feb; 46(1):805-811. PubMed ID: 30515698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China.
    He X; Yao G; Li F; Li M; Yang X
    Int J Mol Sci; 2014 Jan; 15(2):2130-41. PubMed ID: 24481062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
    Li L; Guo G; Wang F; Lv P; Zhu M; Gu Y; Han M; Pei X
    J Cancer Res Ther; 2018; 14(Supplement):S208-S212. PubMed ID: 29578175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population.
    Jiang C; Yu S; Qian P; Guo R; Zhang R; Ao Z; Li Q; Wu G; Chen Y; Li J; Wang C; Yao W; Xu J; Qian G; Ji F
    Oncotarget; 2016 Sep; 7(37):59742-59753. PubMed ID: 27486757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer].
    Chen Q; He Y; Liu C; Liu H; Sun X; Shao Y; Huang T; Xu B
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2783-6. PubMed ID: 26711978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
    Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Association of
    Solis-Coronado O; Villarreal-Vela MP; Rodríguez-Gutiérrez HF; González-Guerrero JF; Cerda-Flores RM; Alcorta-Núñez F; Camarillo-Cárdenas KP; Pérez-Ibave DC; Vidal-Gutiérrez O; Ramírez-Correa GA; Garza-Rodríguez ML
    Curr Oncol; 2022 Feb; 29(2):1008-1017. PubMed ID: 35200585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls.
    Zhang L; Long X
    Sci Rep; 2015 Aug; 5():12773. PubMed ID: 26239137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TOX3 mutations in breast cancer.
    Jones JO; Chin SF; Wong-Taylor LA; Leaford D; Ponder BA; Caldas C; Maia AT
    PLoS One; 2013; 8(9):e74102. PubMed ID: 24069272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic polymorphism in TOX3 is associated with survival of gastric cancer in a Chinese population.
    Zhang X; Zhu H; Wu X; Wang M; Gu D; Gong W; Xu Z; Tan Y; Gong Y; Zhou J; Tang C; Tong N; Chen J; Zhang Z
    PLoS One; 2013; 8(9):e72186. PubMed ID: 24069142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer.
    Han YJ; Zhang J; Zheng Y; Huo D; Olopade OI
    PLoS One; 2016; 11(11):e0165559. PubMed ID: 27806084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNRC9/LOC643714 polymorphisms are not associated with breast cancer risk in Chinese women.
    Li L; Zhou X; Huang Z; Liu Z; Song M; Guo Z
    Eur J Cancer Prev; 2009 Aug; 18(4):285-90. PubMed ID: 19398914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population.
    Elematore I; Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G; Di Capua GA; Jara L
    Mol Biol Rep; 2014 Jun; 41(6):3715-22. PubMed ID: 24532140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the TOX3/LOC643714 and risk of breast cancer in south China.
    Liao J; Chen Y; Zhu J; Wang Q; Mo Z
    Int J Biol Markers; 2018 Apr; ():1724600818755633. PubMed ID: 29683073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.
    Seksenyan A; Kadavallore A; Walts AE; de la Torre B; Berel D; Strom SP; Aliahmad P; Funari VA; Kaye J
    BMC Cancer; 2015 Jan; 15():22. PubMed ID: 25632947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two polymorphisms, rs2046210 and rs3803662, are associated with breast cancer risk in a Vietnamese case-control cohort.
    Thanh NTN; Lan NTT; Phat PT; Giang NDT; Hue NT
    Genes Genet Syst; 2018 Oct; 93(3):101-109. PubMed ID: 30078824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
    Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
    Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.